Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Surrozen Inc., 3 years.
Surrozen Inc.
Director
Cue Biopharma Inc.
Director · Chief Executive Officer
Chief executive roles
Cue Biopharma Inc.
· Chief Executive Officer
Since April 2026
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 13, 2026 | Cue Biopharma Inc. | Open-market sale | −5,423 | $27.19 | $147,451 |
| Aug 13, 2026 | Cue Biopharma Inc. | Open-market sale | −2,375 | $28.11 | $66,761 |
| Aug 13, 2026 | Cue Biopharma Inc. | Open-market sale | −10,460 | $29.48 | $308,361 |
| Aug 12, 2026 | Cue Biopharma Inc. | Option exercise | +109,179 | — | — |
| Aug 12, 2026 | Cue Biopharma Inc. | Open-market sale | −34,225 | $26.99 | $923,733 |
| Aug 12, 2026 | Cue Biopharma Inc. | Open-market sale | −5,775 | $27.75 | $160,256 |
| Jul 9, 2026 | Cue Biopharma Inc. | Grant or award | +327,537 | — | — |
| May 3, 2026 | Cue Biopharma Inc. | Grant or award | +327,537 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.